What Does the Future Hold for KRAS-targeted Therapies?
The future of KRAS-targeted therapies looks promising, driven by ongoing research and clinical trials. Novel drug candidates, improved delivery mechanisms, and better understanding of tumor biology are likely to yield more effective treatments. Additionally, personalized medicine approaches that tailor therapies based on the specific KRAS mutations and other genetic factors of an individual's cancer are expected to improve outcomes.
